MolecuLight specializes in advanced wound care technologies, particularly through its innovative devices, the MolecuLight i:X and DX. These handheld imaging tools utilize fluorescence imaging to detect elevated bacterial burdens in wounds in real-time, providing clinicians with critical information to inform treatment decisions. The devices are designed to enhance wound management by identifying bacterial hotspots that can impede healing, allowing for targeted interventions. Additionally, they offer industry-leading digital wound measurement capabilities, enabling accurate tracking of wound progression without direct patient contact. This integration of imaging and measurement facilitates comprehensive documentation, which is essential for monitoring treatment effectiveness and improving patient outcomes.

The MolecuLight devices are FDA-cleared and CE-marked, ensuring their safety and efficacy in clinical settings. They are integrated with electronic health records (EHRs) and adhere to high security standards, including HIPAA compliance. Clinical evidence supports that using MolecuLight can significantly accelerate wound healing rates and improve overall treatment outcomes, with studies indicating a 79% greater reduction in wound area and double the healing rates compared to standard care practices. By providing a non-invasive, real-time assessment of wound conditions, MolecuLight empowers healthcare professionals to deliver individualized care and optimize wound management strategies.

Canada

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight


MolecuLight

Company Details